• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎进展中的肝细胞损伤和肝干细胞龛。

Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.

机构信息

Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Department of Movement, Human and Health Sciences, Division of Health Sciences, University of Rome "Foro Italico", 00135 Rome, Italy.

出版信息

Cells. 2020 Mar 2;9(3):590. doi: 10.3390/cells9030590.

DOI:10.3390/cells9030590
PMID:32131439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140508/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by lipid accumulation in hepatocytes in the absence of excessive alcohol consumption. The global prevalence of NAFLD is constantly increasing. NAFLD is a disease spectrum comprising distinct stages with different prognoses. Non-alcoholic steatohepatitis (NASH) is a progressive condition, characterized by liver inflammation and hepatocyte ballooning, with or without fibrosis. The natural history of NAFLD is negatively influenced by NASH onset and by the progression towards advanced fibrosis. Pathogenetic mechanisms and cellular interactions leading to NASH and fibrosis involve hepatocytes, liver macrophages, myofibroblast cell subpopulations, and the resident progenitor cell niche. These cells are implied in the regenerative trajectories following liver injury, and impairment or perturbation of these mechanisms could lead to NASH and fibrosis. Recent evidence underlines the contribution of extra-hepatic organs/tissues (e.g., gut, adipose tissue) in influencing NASH development by interacting with hepatic cells through various molecular pathways. The present review aims to summarize the role of hepatic parenchymal and non-parenchymal cells, their mutual influence, and the possible interactions with extra-hepatic tissues and organs in the pathogenesis of NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是一种以肝细胞内脂质蓄积为特征的慢性肝脏疾病,而不存在过量饮酒。全球范围内 NAFLD 的患病率持续上升。NAFLD 是一种疾病谱,包含不同预后的不同阶段。非酒精性脂肪性肝炎(NASH)是一种进行性疾病,其特征为肝脏炎症和肝细胞气球样变,伴有或不伴有纤维化。NASH 的发生和向晚期纤维化的进展对 NAFLD 的自然病程产生负面影响。导致 NASH 和纤维化的发病机制和细胞相互作用涉及肝细胞、肝巨噬细胞、肌成纤维细胞亚群和固有祖细胞龛。这些细胞参与肝脏损伤后的再生轨迹,这些机制的损害或紊乱可能导致 NASH 和纤维化。最近的证据强调了肝外器官/组织(例如肠道、脂肪组织)通过各种分子途径与肝细胞相互作用,对 NASH 发展的影响。本综述旨在总结肝实质细胞和非实质细胞的作用、它们之间的相互影响以及与肝外组织和器官的可能相互作用在 NAFLD 发病机制中的作用。

相似文献

1
Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.非酒精性脂肪性肝炎进展中的肝细胞损伤和肝干细胞龛。
Cells. 2020 Mar 2;9(3):590. doi: 10.3390/cells9030590.
2
CD44 is a key player in non-alcoholic steatohepatitis.CD44 是非酒精性脂肪性肝炎的关键参与者。
J Hepatol. 2017 Aug;67(2):328-338. doi: 10.1016/j.jhep.2017.03.003. Epub 2017 Mar 16.
3
The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.转录因子 c-Jun/AP-1 通过调节骨桥蛋白表达促进非酒精性脂肪性肝炎肝纤维化。
Cell Death Differ. 2019 Sep;26(9):1688-1699. doi: 10.1038/s41418-018-0239-8. Epub 2019 Feb 18.
4
Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis.单细胞数据分析揭示非酒精性脂肪性肝病进展为非酒精性脂肪性肝炎过程中的关键肝细胞亚群。
Comb Chem High Throughput Screen. 2024 May 27. doi: 10.2174/0113862073303213240523095742.
5
Metabolic drivers of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的代谢驱动因素。
Mol Metab. 2021 Aug;50:101143. doi: 10.1016/j.molmet.2020.101143. Epub 2020 Dec 17.
6
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies.非酒精性脂肪性肝炎中的慢性炎症:分子机制与治疗策略。
Front Endocrinol (Lausanne). 2020 Dec 14;11:597648. doi: 10.3389/fendo.2020.597648. eCollection 2020.
7
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.
8
Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)中细胞可塑性的动态变化。
Biochim Biophys Acta Mol Basis Dis. 2024 Apr;1870(4):167102. doi: 10.1016/j.bbadis.2024.167102. Epub 2024 Feb 28.
9
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.非酒精性脂肪性肝病:从非酒精性脂肪性肝病到非酒精性脂肪性肝炎的进展中的基本发病机制。
Transplantation. 2019 Jan;103(1):e1-e13. doi: 10.1097/TP.0000000000002480.
10
Mechanisms of ductular reaction in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎中胆小管反应的机制。
World J Gastroenterol. 2022 May 21;28(19):2088-2099. doi: 10.3748/wjg.v28.i19.2088.

引用本文的文献

1
Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities.解读肝纤维化-肝细胞癌轴:从机制到治疗机遇
Hepatol Int. 2025 Jul 1. doi: 10.1007/s12072-025-10838-y.
2
From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood.从儿童肥胖到儿童期氧化应激导致的代谢功能障碍相关脂肪性肝病(MASLD)和高脂血症。
Metabolites. 2025 Apr 24;15(5):287. doi: 10.3390/metabo15050287.
3
Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease.

本文引用的文献

1
In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.在脂肪变性细胞中,ATP-柠檬酸裂解酶 mRNA 通过一种帽非依赖性机制进行有效的翻译,有助于刺激从头合成脂肪。
Int J Mol Sci. 2020 Feb 11;21(4):1206. doi: 10.3390/ijms21041206.
2
Chronic Microcystin-LR Exposure Induces Abnormal Lipid Metabolism via Endoplasmic Reticulum Stress in Male Zebrafish.慢性微囊藻毒素-LR 通过内质网应激诱导雄性斑马鱼异常脂质代谢。
Toxins (Basel). 2020 Feb 7;12(2):107. doi: 10.3390/toxins12020107.
3
Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action.
代谢相关脂肪性肝病患者残余胆固醇与胰岛素抵抗水平的相关性。
Sci Rep. 2024 Feb 26;14(1):4596. doi: 10.1038/s41598-024-55282-4.
4
Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues.非酒精性脂肪性肝炎中的肝细胞气球样变:弥合知识差距与规划未来方向
Cureus. 2023 Sep 25;15(9):e45884. doi: 10.7759/cureus.45884. eCollection 2023 Sep.
5
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies.非酒精性脂肪性肝病与肠道微生物失调:潜在机制和肠道微生物介导的治疗策略。
Rev Endocr Metab Disord. 2023 Dec;24(6):1189-1204. doi: 10.1007/s11154-023-09843-z. Epub 2023 Oct 16.
6
Cell transplantation-based regenerative medicine in liver diseases.基于细胞移植的肝脏疾病再生医学。
Stem Cell Reports. 2023 Aug 8;18(8):1555-1572. doi: 10.1016/j.stemcr.2023.06.005.
7
Customized liver organoids as an advanced modeling and drug discovery platform for non-alcoholic fatty liver diseases.定制化的肝脏类器官作为一种先进的非酒精性脂肪性肝病建模和药物发现平台。
Int J Biol Sci. 2023 Jul 9;19(11):3595-3613. doi: 10.7150/ijbs.85145. eCollection 2023.
8
Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted.非酒精性脂肪性肝病中的小胆管反应:当麦克白被扭曲时。
World J Hepatol. 2023 Jun 27;15(6):725-740. doi: 10.4254/wjh.v15.i6.725.
9
Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis.源自肝细胞的外泌体葡萄糖转运蛋白1可识别非酒精性脂肪性肝炎和肝纤维化的风险。
Hepatol Int. 2023 Oct;17(5):1170-1181. doi: 10.1007/s12072-023-10520-1. Epub 2023 Jun 6.
10
Bavachin protects against diet-induced hepatic steatosis and obesity in mice.巴维亭可预防小鼠饮食诱导的肝脂肪变性和肥胖。
Acta Pharmacol Sin. 2023 Jul;44(7):1416-1428. doi: 10.1038/s41401-023-01056-z. Epub 2023 Jan 31.
维生素 D 缺乏大鼠胰岛素底物-1 和胰岛素底物-2 信号失衡引发肝脂肪变性:8-甲氧基补骨脂素,一种具有潜在抗脂肪变性作用的维生素 D 受体配体。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Jun;1865(6):158657. doi: 10.1016/j.bbalip.2020.158657. Epub 2020 Feb 8.
4
Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH.非酒精性脂肪性肝炎患者肝脏PNPLA3表达的代谢调节与肝纤维化严重程度
Liver Int. 2020 May;40(5):1098-1110. doi: 10.1111/liv.14402. Epub 2020 Mar 1.
5
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.PRO-C3胶原蛋白新表位生物标志物在非酒精性脂肪性肝病中的表现
JHEP Rep. 2019 Jul 4;1(3):188-198. doi: 10.1016/j.jhepr.2019.06.004. eCollection 2019 Sep.
6
Involvement of Endoplasmic Reticulum Stress in Palmitate-induced Apoptosis in HepG2 Cells.内质网应激参与棕榈酸诱导的HepG2细胞凋亡
Toxicol Res. 2008 Jun;24(2):129-135. doi: 10.5487/TR.2008.24.2.129. Epub 2008 Jun 1.
7
MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1.MicroRNA-103 通过靶向 FASN 和 SCD1 抑制肝内从头脂肪生成并缓解非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2020 Apr 9;524(3):716-722. doi: 10.1016/j.bbrc.2020.01.143. Epub 2020 Feb 5.
8
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.AMPK-caspase-6 轴控制非酒精性脂肪性肝炎中的肝损伤。
Science. 2020 Feb 7;367(6478):652-660. doi: 10.1126/science.aay0542.
9
Oleic acid ameliorates palmitic acid induced hepatocellular lipotoxicity by inhibition of ER stress and pyroptosis.油酸通过抑制内质网应激和细胞焦亡改善棕榈酸诱导的肝细胞脂肪毒性。
Nutr Metab (Lond). 2020 Jan 30;17:11. doi: 10.1186/s12986-020-0434-8. eCollection 2020.
10
Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD.缺乏 IL-1β 激活基因 Prtn3、Elane 和 Casp1 的小鼠可预防肥胖诱导的非酒精性脂肪性肝病的发生。
Inflammation. 2020 Jun;43(3):1054-1064. doi: 10.1007/s10753-020-01190-4.